Literature DB >> 11122946

Genetic analyses of schizophrenia.

C N Pato1, K M Schindler, M T Pato.   

Abstract

Although evidence exists to support a heritable component to schizophrenia, few details are understood about the genetics of the disorder. Presently, molecular genetic techniques provide the most promise in uncovering the genetic mechanisms of disease. Candidate gene analyses and linkage studies have opened some prospective avenues for exploration. Clearer findings from these studies many be hidden by the syndromic nature of schizophrenia. The study of more genetically homogenous populations and symptom-based phenotypic subtypes may help to make this genetic data more revealing. This review highlights some of the latest progress and findings in the molecular genetic analyses of schizophrenia, including both candidate gene analyses and genome scan studies.

Entities:  

Mesh:

Year:  2000        PMID: 11122946     DOI: 10.1007/s11920-000-0058-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  57 in total

1.  Linkage analysis of a large Swedish kindred provides further support for a susceptibility locus for schizophrenia on chromosome 6p23.

Authors:  E Lindholm; B Ekholm; J Balciuniene; G Johansson; A Castensson; M Koisti; P O Nylander; U Pettersson; R Adolfsson; E Jazin
Journal:  Am J Med Genet       Date:  1999-08-20

2.  Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communication.

Authors:  G Stöber; S Jatzke; A Heils; G Jungkunz; M Knapp; R Mössner; P Riederer; K P Lesch
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

3.  A schizophrenia locus may be located in region 10p15-p11.

Authors:  R E Straub; C J MacLean; R B Martin; Y Ma; M V Myakishev; C Harris-Kerr; B T Webb; F A O'Neill; D Walsh; K S Kendler
Journal:  Am J Med Genet       Date:  1998-07-10

4.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium.

Authors:  S V Faraone; T Matise; D Svrakic; J Pepple; D Malaspina; B Suarez; C Hampe; C T Zambuto; K Schmitt; J Meyer; P Markel; H Lee; J Harkavy Friedman; C Kaufmann; C R Cloninger; M T Tsuang
Journal:  Am J Med Genet       Date:  1998-07-10

5.  Genome scan of schizophrenia.

Authors:  D F Levinson; M M Mahtani; D J Nancarrow; D M Brown; L Kruglyak; A Kirby; N K Hayward; R R Crowe; N C Andreasen; D W Black; J M Silverman; J Endicott; L Sharpe; R C Mohs; L J Siever; M K Walters; D P Lennon; H L Jones; D A Nertney; M J Daly; M Gladis; B J Mowry
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

6.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

7.  Two-locus models of disease: comparison of likelihood and nonparametric linkage methods.

Authors:  L R Goldin; D E Weeks
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

8.  Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families.

Authors:  K S Kendler; C J MacLean; F A O'Neill; J Burke; B Murphy; F Duke; R Shinkwin; S M Easter; B T Webb; J Zhang; D Walsh; R E Straub
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

9.  Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.

Authors:  K Ohara; M Nagai; K Tani; Y Nakamura; A Ino; K Ohara
Journal:  Psychiatry Res       Date:  1998-11-16       Impact factor: 3.222

10.  A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

Authors:  G Spurlock; A Heils; P Holmans; J Williams; U M D'Souza; A Cardno; K C Murphy; L Jones; P R Buckland; P McGuffin; K P Lesch; M J Owen
Journal:  Mol Psychiatry       Date:  1998-01       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.